Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

about

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

Item

http://www.wikidata.org/entity/Q55236793

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

@en

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

@nl

type

Item

label

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

@en

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

@nl

prefLabel

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

@en

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

@nl

P1476

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

@en

P2093

Janine Stuart

http://www.w3.org/2001/XMLSchema#string

Jeffrey Lipman

http://www.w3.org/2001/XMLSchema#string

Jenie Butler

http://www.w3.org/2001/XMLSchema#string

Saurabh Pandey

http://www.w3.org/2001/XMLSchema#string

Steven C Wallis

http://www.w3.org/2001/XMLSchema#string

Therese Starr

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents

Posaconazole: an extended-spectrum triazole antifungal agent

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

APACHE II: a severity of disease classification system

Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.

Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

P31

scholarly article

P356

10.1128/AAC.00242-18

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jason A. Roberts

Fekade Bruck Sime

P577

2018-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29581122

http://www.w3.org/2001/XMLSchema#string

P932

5971586

http://www.w3.org/2001/XMLSchema#string